227 related articles for article (PubMed ID: 34925039)
1. Alpha/Beta-Hydrolase Domain-Containing 6: Signaling and Function in the Central Nervous System.
Zhang H; Li X; Liao D; Luo P; Jiang X
Front Pharmacol; 2021; 12():784202. PubMed ID: 34925039
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic potential of targeting α/β-Hydrolase domain-containing 6 (ABHD6).
Deng H; Li W
Eur J Med Chem; 2020 Jul; 198():112353. PubMed ID: 32371333
[TBL] [Abstract][Full Text] [Related]
3. Monoacylglycerol signalling and ABHD6 in health and disease.
Poursharifi P; Madiraju SRM; Prentki M
Diabetes Obes Metab; 2017 Sep; 19 Suppl 1():76-89. PubMed ID: 28880480
[TBL] [Abstract][Full Text] [Related]
4. α/β-Hydrolase Domain-Containing 6 (ABHD6)- A Multifunctional Lipid Hydrolase.
Pusch LM; Riegler-Berket L; Oberer M; Zimmermann R; Taschler U
Metabolites; 2022 Aug; 12(8):. PubMed ID: 36005632
[TBL] [Abstract][Full Text] [Related]
5. Carnitine palmitoyltransferase 1C negatively regulates the endocannabinoid hydrolase ABHD6 in mice, depending on nutritional status.
Miralpeix C; Reguera AC; Fosch A; Casas M; Lillo J; Navarro G; Franco R; Casas J; Alexander SPH; Casals N; Rodríguez-Rodríguez R
Br J Pharmacol; 2021 Apr; 178(7):1507-1523. PubMed ID: 33444462
[TBL] [Abstract][Full Text] [Related]
6. ABHD6: Its Place in Endocannabinoid Signaling and Beyond.
Cao JK; Kaplan J; Stella N
Trends Pharmacol Sci; 2019 Apr; 40(4):267-277. PubMed ID: 30853109
[TBL] [Abstract][Full Text] [Related]
7. Re-examining the potential of targeting ABHD6 in multiple sclerosis: Efficacy of systemic and peripherally restricted inhibitors in experimental autoimmune encephalomyelitis.
Manterola A; Bernal-Chico A; Cipriani R; Ruiz A; Pérez-Samartín A; Moreno-Rodríguez M; Hsu KL; Cravatt BF; Brown JM; Rodríguez-Puertas R; Matute C; Mato S
Neuropharmacology; 2018 Oct; 141():181-191. PubMed ID: 30171986
[TBL] [Abstract][Full Text] [Related]
8. Structural properties and role of the endocannabinoid lipases ABHD6 and ABHD12 in lipid signalling and disease.
Kind L; Kursula P
Amino Acids; 2019 Feb; 51(2):151-174. PubMed ID: 30564946
[TBL] [Abstract][Full Text] [Related]
9. Comparative molecular field analysis and molecular dynamics studies of α/β hydrolase domain containing 6 (ABHD6) inhibitors.
Kaczor AA; Targowska-Duda KM; Patel JZ; Laitinen T; Parkkari T; Adams Y; Nevalainen TJ; Poso A
J Mol Model; 2015 Oct; 21(10):250. PubMed ID: 26350245
[TBL] [Abstract][Full Text] [Related]
10. α/β-Hydrolase domain-6 and saturated long chain monoacylglycerol regulate insulin secretion promoted by both fuel and non-fuel stimuli.
Zhao S; Poursharifi P; Mugabo Y; Levens EJ; Vivot K; Attane C; Iglesias J; Peyot ML; Joly E; Madiraju SR; Prentki M
Mol Metab; 2015 Dec; 4(12):940-50. PubMed ID: 26909310
[TBL] [Abstract][Full Text] [Related]
11. WWL70 protects against chronic constriction injury-induced neuropathic pain in mice by cannabinoid receptor-independent mechanisms.
Wen J; Jones M; Tanaka M; Selvaraj P; Symes AJ; Cox B; Zhang Y
J Neuroinflammation; 2018 Jan; 15(1):9. PubMed ID: 29310667
[TBL] [Abstract][Full Text] [Related]
12. Deregulation of the endocannabinoid system and therapeutic potential of ABHD6 blockade in the cuprizone model of demyelination.
Manterola A; Bernal-Chico A; Cipriani R; Canedo-Antelo M; Moreno-García Á; Martín-Fontecha M; Pérez-Cerdá F; Sánchez-Gómez MV; Ortega-Gutiérrez S; Brown JM; Hsu KL; Cravatt B; Matute C; Mato S
Biochem Pharmacol; 2018 Nov; 157():189-201. PubMed ID: 30075103
[TBL] [Abstract][Full Text] [Related]
13. Activation of CB2 receptor is required for the therapeutic effect of ABHD6 inhibition in experimental autoimmune encephalomyelitis.
Wen J; Ribeiro R; Tanaka M; Zhang Y
Neuropharmacology; 2015 Dec; 99():196-209. PubMed ID: 26189763
[TBL] [Abstract][Full Text] [Related]
14. Biochemical and pharmacological characterization of human α/β-hydrolase domain containing 6 (ABHD6) and 12 (ABHD12).
Navia-Paldanius D; Savinainen JR; Laitinen JT
J Lipid Res; 2012 Nov; 53(11):2413-24. PubMed ID: 22969151
[TBL] [Abstract][Full Text] [Related]
15. UPLC-MS/MS Method for Analysis of Endocannabinoid and Related Lipid Metabolism in Mouse Mucosal Tissue.
Wiley MB; Perez PA; Argueta DA; Avalos B; Wood CP; DiPatrizio NV
Front Physiol; 2021; 12():699712. PubMed ID: 34335305
[TBL] [Abstract][Full Text] [Related]
16. Discovery and optimization of piperidyl-1,2,3-triazole ureas as potent, selective, and in vivo-active inhibitors of α/β-hydrolase domain containing 6 (ABHD6).
Hsu KL; Tsuboi K; Chang JW; Whitby LR; Speers AE; Pugh H; Cravatt BF
J Med Chem; 2013 Nov; 56(21):8270-9. PubMed ID: 24152295
[TBL] [Abstract][Full Text] [Related]
17. Utilizing PET and MALDI Imaging for Discovery of a Targeted Probe for Brain Endocannabinoid
Mardon K; Patel JZ; Savinainen JR; Stimson DHR; Oyagawa CRM; Grimsey NL; Migotto MA; Njiru GFM; Hamilton BR; Cowin G; Yli-Kauhaluoma J; Vanduffel W; Blakey I; Bhalla R; Cawthorne C; Celen S; Bormans G; Thurecht KJ; Ahamed M
J Med Chem; 2023 Jan; 66(1):538-552. PubMed ID: 36516997
[TBL] [Abstract][Full Text] [Related]
18. A Sensitive and Versatile Fluorescent Activity Assay for ABHD6.
Savinainen JR; Navia-Paldanius D; Laitinen JT
Methods Mol Biol; 2016; 1412():169-78. PubMed ID: 27245903
[TBL] [Abstract][Full Text] [Related]
19. WWL70 attenuates PGE
Tanaka M; Moran S; Wen J; Affram K; Chen T; Symes AJ; Zhang Y
J Neuroinflammation; 2017 Jan; 14(1):7. PubMed ID: 28086912
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
